244 filings
8-K
XNCR
Xencor Inc
14 Jun 24
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
XNCR
Xencor Inc
13 Jun 24
Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
8:05am
8-K
XNCR
Xencor Inc
9 May 24
Xencor Reports First Quarter 2024 Financial Results
4:11pm
10-Q
2024 Q1
XNCR
Xencor Inc
Quarterly report
9 May 24
4:02pm
ARS
2023 FY
XNCR
Xencor Inc
24 Apr 24
Annual report to shareholders
4:08pm
DEFA14A
youbndaw26 mg
24 Apr 24
Additional proxy soliciting materials
4:07pm
8-K
dhxlu7 2vwa9rcm
9 Apr 24
Xencor Appoints Bart Cornelissen as Chief Financial Officer
8:20am
8-K
mjhcltsw azkc
6 Mar 24
Regulation FD Disclosure
8:32am
8-K
05m6ld4kuamoddsnm
27 Feb 24
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
1gvrn7kcaoaq
15 Nov 23
Entry into a Material Definitive Agreement
4:02pm
8-K
7snmaww4
7 Nov 23
Xencor Reports Third Quarter 2023 Financial Results
4:04pm
8-K
fsdko
7 Nov 23
Entry into a Material Definitive Agreement
4:03pm
8-K
pgydrg3c
26 Oct 23
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
8:11am
8-K
mmbaiqd
19 Sep 23
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
4:31pm
8-K
dt8scc1ta287vgcms
3 Aug 23
Xencor Reports Second Quarter 2023 Financial Results
4:02pm
8-K
0iop8j
3 Jul 23
Departure of Directors or Certain Officers
7:16am